Clinical Trial Update: Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for wedge resection in lung cancer with ground-glass opacity features; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Fudan University | Conditions: Lung Cancer, Wedge Resection | Phase 3 | Status: NOT_YET_RECRUITING